#immunocompromise — Wednesday, February 04, 2026 (1 items)
| 0 | ℹ |
Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-04 | #infection #immunity #immunotherapy #immunocompromise |